Related Experiment Video
Updated: Sep 6, 2025

03:37
Author Spotlight: Enhancing Cerebral Ischemia Research with a Simplified Rat Model
Published on: July 5, 2024
695
The Curing Coma Campaign and the Future of Coma Research
DaiWai M Olson1, J Claude Hemphill2, J Javier Provencio3
1Department of Neurology, University of Texas Southwestern, Dallas, Texas.
Seminars in Neurology
|June 29, 2022
Summary
Understanding coma recovery after acute brain injury is crucial. The Curing Coma Campaign aims to bridge knowledge gaps and advance research for better patient outcomes.
Area of Science:
- Neuroscience
- Critical Care Medicine
- Neurology
Background:
- Recovery from coma after acute brain injury (stroke, trauma, cardiac arrest, infections) remains poorly understood.
- Significant gaps in scientific knowledge hinder accurate prognostication and effective interventions for coma recovery.
- Recent research is beginning to uncover mechanisms of consciousness post-brain injury and test pilot interventions.
Purpose of the Study:
- To address the critical need for improved understanding and treatment of coma and disordered consciousness.
- To establish a collaborative platform for research, education, and advocacy in coma recovery.
- To accelerate scientific progress and clinical translation for patients with acute brain injuries.
Main Methods:
- Development of the Curing Coma Campaign in 2019 by the Neurocritical Care Society.
- Establishment of scientific working groups and operational modules.
- Creation of a comprehensive 10-year roadmap for coma research and intervention.
Main Results:
- The Curing Coma Campaign provides a vital infrastructure for interdisciplinary scientific collaboration.
- It empowers a community dedicated to advancing coma recovery science and patient care.
- The campaign has laid the groundwork for a structured, long-term approach to this 'grand challenge'.
Conclusions:
- The Curing Coma Campaign represents a significant, coordinated effort to tackle the complexities of coma recovery.
- It aims to translate scientific discoveries into improved clinical practices and patient outcomes.
- This initiative is poised to drive substantial progress in the field of neurocritical care over the next decade.
Related Concept Videos
Curing Methods
120
Concrete members with a small surface-to-volume ratio are cured by oiling and moistening the forms before casting the concrete member. These forms can be left in place for a prolonged period to prevent moisture loss, and can be wetted if made of a material suitable for wetting. If the forms are removed early, the concrete member is moistened and covered with polythene sheets to maintain moisture. For large horizontal concrete surfaces exposed to dry weather, a temporary covering is suspended...
120
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Curing of Concrete
164
The hydration of cement takes place within the water-filled capillary pores. However, environmental elements can disrupt this process by evaporating water from the concrete surfaces. Sealed concrete with a water-cement ratio below 0.5 experiences self-desiccation, leading to water loss. The water loss in concrete is mitigated by curing. This technique involves keeping the concrete saturated to maintain the necessary temperature and moisture conditions, to optimally fill the spaces in the cement...
164
Psychosis: Goals of Pharmacotherapy
207
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
207
Electroconvulsive Therapy
139
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
139
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K

